These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 9930345)
1. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells. Wendelburg BJ; Vos JM Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345 [TBL] [Abstract][Full Text] [Related]
2. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells. Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710 [TBL] [Abstract][Full Text] [Related]
3. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Nilsson T; Sjöblom A; Masucci MG; Rymo L Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755 [TBL] [Abstract][Full Text] [Related]
4. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells. Kishida T; Asada H; Kubo K; Sato YT; Shin-Ya M; Imanishi J; Yoshikawa K; Mazda O J Biotechnol; 2008 Jan; 133(2):201-7. PubMed ID: 17935815 [TBL] [Abstract][Full Text] [Related]
5. Construction of Epstein-Barr virus-based expression vector containing mini-oriP. Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034 [TBL] [Abstract][Full Text] [Related]
6. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha. Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725 [TBL] [Abstract][Full Text] [Related]
7. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression. Shan L; Wang L; Yin J; Zhong P; Zhong J J Gene Med; 2006 Dec; 8(12):1400-6. PubMed ID: 17051599 [TBL] [Abstract][Full Text] [Related]
8. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication. Van Scoy S; Watakabe I; Krainer AR; Hearing J Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796 [TBL] [Abstract][Full Text] [Related]
9. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance. Deakyne JS; Malecka KA; Messick TE; Lieberman PM J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406 [TBL] [Abstract][Full Text] [Related]
10. [Progress of EBNA1/oriP-based plasmid applied in gene therapy]. He J; Zhang ZQ Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Yates JL; Camiolo SM; Ali S; Ying A Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482 [TBL] [Abstract][Full Text] [Related]
12. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669 [TBL] [Abstract][Full Text] [Related]
13. Replication licensing of the EBV oriP minichromosome. Hirai K; Shirakata M Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396 [TBL] [Abstract][Full Text] [Related]
16. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells. Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388 [TBL] [Abstract][Full Text] [Related]
17. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364 [TBL] [Abstract][Full Text] [Related]
18. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242 [TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice. Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice. Stoll SM; Sclimenti CR; Baba EJ; Meuse L; Kay MA; Calos MP Mol Ther; 2001 Aug; 4(2):122-9. PubMed ID: 11482983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]